2014
DOI: 10.1016/j.ajme.2013.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Fluconazole and selective digestive decontamination for prevention of Candida infection in high risk critically ill patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Fluconazole is a triazole antifungal agent that is clinically widely used due to its advantages of excellent bioavailability and low toxicity [ 23 ]. Fluconazole was added into organic phase solution to prepare micelles with their hydrophobic cores loaded with the drug.…”
Section: Resultsmentioning
confidence: 99%
“…Fluconazole is a triazole antifungal agent that is clinically widely used due to its advantages of excellent bioavailability and low toxicity [ 23 ]. Fluconazole was added into organic phase solution to prepare micelles with their hydrophobic cores loaded with the drug.…”
Section: Resultsmentioning
confidence: 99%
“…have risen considerably in recent years and represent a crescent global health problem (G acser et al 2014). The increase of infections like mucosal and systemic candidiasis can be explained by a high number of patients at risk, like as the possibility of these yeasts to invade unharmed tissues (Beshey et al 2013). Patients are receiving chemotherapy; transplant recipients and diabetics are more susceptible to fungal infections because they are with their impaired immunity (Kathiravan et al 2012).…”
Section: Introductionmentioning
confidence: 99%